[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @PsychedVantage Psychedelic Vantage Psychedelic Vantage posts on X about $atai, $cybn, atai life, $cmps the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1461655010958315520/interactions)  - X Week XXXXXX +26% - X Month XXXXXX -XX% - X Months XXXXXXX +127% - X Year XXXXXXX +491% ### Mentions: XX [#](/creator/twitter::1461655010958315520/posts_active)  - X Week XX +67% - X Month XX +2.10% - X Months XXX +127% - X Year XXX +225% ### Followers: XXXXX [#](/creator/twitter::1461655010958315520/followers)  - X Week XXXXX +2.40% - X Month XXXXX +3.80% - X Months XXXXX +42% - X Year XXXXX +50% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1461655010958315520/influencer_rank)  ### Social Influence [#](/creator/twitter::1461655010958315520/influence) --- **Social category influence** [stocks](/list/stocks) XXXXX% [finance](/list/finance) XXXX% [currencies](/list/currencies) XXXX% **Social topic influence** [$atai](/topic/$atai) #6, [$cybn](/topic/$cybn) 7.91%, [atai life](/topic/atai-life) #6, [$cmps](/topic/$cmps) 3.6%, [$mnmd](/topic/$mnmd) 3.6%, [$ghrs](/topic/$ghrs) 2.88%, [investment](/topic/investment) 2.16%, [$anro](/topic/$anro) 1.44%, [$vtgn](/topic/$vtgn) 1.44%, [$abbv](/topic/$abbv) XXXX% **Top accounts mentioned or mentioned by** [@c2412345](/creator/undefined) [@brandon_job23](/creator/undefined) [@cangermayer](/creator/undefined) [@psychedalpha](/creator/undefined) [@fiwlsp](/creator/undefined) [@insidepharma](/creator/undefined) [@kukeon2022](/creator/undefined) [@beckleypsytech](/creator/undefined) [@atailife](/creator/undefined) [@alphaporgs](/creator/undefined) [@brandonjob23](/creator/undefined) [@jedisrle](/creator/undefined) [@bigdogback](/creator/undefined) [@smallpharma](/creator/undefined) [@cangermayers](/creator/undefined) [@hildeshiem1](/creator/undefined) [@nftlunatic](/creator/undefined) [@investingincan1](/creator/undefined) [@zetaboy69](/creator/undefined) [@mattbro32211486](/creator/undefined) **Top assets mentioned** [ATAI Life Sciences (ATAI)](/topic/$atai) [AbbVie Inc (ABBV)](/topic/$abbv) [Hundred Million (100M)](/topic/$100m) ### Top Social Posts [#](/creator/twitter::1461655010958315520/posts) --- Top posts by engagements in the last XX hours "@C_Angermayer @atai_life Congratulations @C_Angermayer and to the entire team at @atai_life and @BeckleyPsytech" [X Link](https://x.com/PsychedVantage/status/1979166155957772600) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-17T12:42Z 1521 followers, XXX engagements "We shall see. If we take the rumors seriously from the recent piece put out by @Bloomberg then perhaps it wouldnt be so surprising. Separately Atai Life Sciences NV is working with an investment bank to field early stage interest from major industry players the people said. The Peter Thiel-backed firm which recently acquired Beckley Psytech has received positive results from a recent mid-stage trial of a psychedelic nasal spray dubbed BPL-003. A representative for Atai declined to comment. Time will tell. -Jake" [X Link](https://x.com/PsychedVantage/status/1958564182758191288) [@PsychedVantage](/creator/x/PsychedVantage) 2025-08-21T16:17Z 1498 followers, XXX engagements "atai Life Sciences Awarded Grant from the National Institutes of Health $ATAI" [X Link](https://x.com/PsychedVantage/status/1968669316758348086) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-18T13:31Z 1497 followers, 2616 engagements "When/if Pharma makes another move on short acting psychedelics which program is their most likely target $CYBN $ATAI $GHRS" [X Link](https://x.com/PsychedVantage/status/1972678347759980830) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-29T15:02Z 1504 followers, XXX engagements "$ATAI $ARKG" [X Link](https://x.com/PsychedVantage/status/1975370518707716236) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-07T01:20Z 1499 followers, 2118 engagements "$ATAI October 2025 Corporate Presentation" [X Link](https://x.com/PsychedVantage/status/1975579808848339176) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-07T15:11Z 1499 followers, 2723 engagements "@c2412345 @Matt_vlietstra @Thegaucher1 Ya I sold out for a loss. Only individual stocks I hold rn are $ATAI $CMPS $ANRO and $VTGN. I could potentially see myself re-entering $CYBN at some point. We shall see. -Jake" [X Link](https://x.com/PsychedVantage/status/1976307133671968971) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-09T15:21Z 1505 followers, XXX engagements "AbbVie acquired Gilgameshs GM-2505 (bretisilocin) in a deal worth up to $1.2B. The upfront wasnt disclosed. Whats your estimate for the upfront payment (No royalties mentioned; GM-2505 has been IV in trials with an IM formulation planned) $CMPS $MNMD $CYBN $ATAI $GHRS" [X Link](https://x.com/PsychedVantage/status/1962621388818112828) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-01T20:59Z 1510 followers, 1266 engagements "Updated neuropsychiatry drug development portfolio allocation (Individual + Roth IRA) Today I sold around XX% of my $ATAI position and for a simple reason: Not only was $ATAI very overweight in my neuropsychiatry drug development portfolio it was starting to make up an uncomfortably large share of my overall net worth. (I still think this stock has a lot of upside potential in the short medium and longterm/not financial or investment advice). As always this is not investment advice. I share to stay transparent and spark conversation in the community. -Jake" [X Link](https://x.com/PsychedVantage/status/1970591031256052027) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-23T20:48Z 1505 followers, 3358 engagements "Some personal thoughts/opinions/predictions (I reserve the right to be wrong): $CMPS $MNMD $CYBN $ATAI $GHRS $CMPS COMP005 XX week data could underwhelm investors (potentially being shared in Q1 2026 though no official guidance from $CMPS yet as far as Im aware). As I have shared many times I am much more bullish on COMP006 data. BPL-003 will eventually be granted BTD. $ATAI needs more cash. Will they partner up Raise a new round What valuation will healthcare investors be comfortable with $CMPS head start in the space may be more than some anticipated. With more companies running large phase" [X Link](https://x.com/PsychedVantage/status/1971303340492366255) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-25T19:58Z 1505 followers, 2911 engagements "Although 5-MeO-DMT is in later stages of development and has shown a lot of promise: for the treatment of depression/anxiety specifically I am most excited about the potential of NN-DMT. Great to see $ATAI and $CYBN using two-dose induction models in their phase X trials in TRD and GAD (with co-morbid depression allowed). Most optimistic about the potential of 5-MeO-DMT for substance use disorders. (Not included on list)-Does atai/Beckley find a buyer for ELE-101 I like the idea of a short-acting psilocybin-like candidate (Perhaps a better tolerated psychedelic when compared to NN/5-MeO-DMT)" [X Link](https://x.com/PsychedVantage/status/1972678349928419442) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-29T15:02Z 1504 followers, XXX engagements "Updated neuropsychiatry drug development portfolio allocation (Individual + Roth IRA) I cut losses with $CYBN and spread money around to $ATAI $CMPS $VTGN $NEUP (new position) $VOO and $VTI As always this is not investment advice. I share to stay transparent and spark conversation in the community. -Jake" [X Link](https://x.com/PsychedVantage/status/1973055674968908280) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-30T16:01Z 1504 followers, 3132 engagements "Updates: Chickened out and sold $NEUP for a XX% gain. Not investment advice. -Jake" [X Link](https://x.com/PsychedVantage/status/1975557556509782023) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-07T13:43Z 1514 followers, XXX engagements "Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones $CYBN" [X Link](https://x.com/PsychedVantage/status/1970595295609197002) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-23T21:05Z 1515 followers, XXX engagements "I like $MNMD. Just like the other names I currently hold more. I could see myself potentially buying some in the future. Yeah to me at least a bet on $CYBN is a bet that they partner up for both CYB003 and CYB004 or get bought out. I think CYB004 is a special program excited to see data when it is released in Q1 2026. Not quite convinced yet that CYB003 is that much differentiated from COMP360. -Jake" [X Link](https://x.com/PsychedVantage/status/1976314172267704453) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-09T15:49Z 1515 followers, XXX engagements "atai Life Sciences Announces Proposed Public Offering of Common Shares $ATAI" [X Link](https://x.com/PsychedVantage/status/1978917961189490898) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-16T20:16Z 1518 followers, 2148 engagements "Cybin to Participate in the Cantor Global Healthcare Conference 2025 $CYBN" [X Link](https://x.com/PsychedVantage/status/1963203236166299912) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-03T11:31Z 1515 followers, 1030 engagements "The Complete Response Letter (CRL) issued to Lykos Therapeutics is now publicly available $CMPS $MNMD $CYBN $ATAI $GHRS" [X Link](https://x.com/PsychedVantage/status/1963635185678774541) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-04T16:08Z 1515 followers, 2397 engagements "Cybin Completes Enrollment in Phase X Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder $CYBN" [X Link](https://x.com/PsychedVantage/status/1965015235108176100) [@PsychedVantage](/creator/x/PsychedVantage) 2025-09-08T11:31Z 1515 followers, 1056 engagements "Indeed. Very exciting news. 🐸 Interested to see the pricing of the proposed public offering. $ATAI" [X Link](https://x.com/PsychedVantage/status/1978931365769892063) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-16T21:09Z 1520 followers, 2392 engagements "atai Life Sciences Announces Pricing of Public Offering of Common Shares $ATAI" [X Link](https://x.com/PsychedVantage/status/1979012977836601377) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-17T02:33Z 1520 followers, 3033 engagements "Close Priced at $XXXX. Great to see $ATAI raising at this valuation curious to see which investors participated when that list comes out" [X Link](https://x.com/PsychedVantage/status/1979014988116181188) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-17T02:41Z 1520 followers, 2486 engagements "AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin" [X Link](https://x.com/PsychedVantage/status/1979194096510976096) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-17T14:33Z 1518 followers, XXX engagements "$MNMD surpasses $X billion dollar market cap" [X Link](https://x.com/PsychedVantage/status/1979271935524556879) [@PsychedVantage](/creator/x/PsychedVantage) 2025-10-17T19:42Z 1521 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@PsychedVantage Psychedelic Vantage
Psychedelic Vantage posts on X about $atai, $cybn, atai life, $cmps the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX +26%
- X Month XXXXXX -XX%
- X Months XXXXXXX +127%
- X Year XXXXXXX +491%
Mentions: XX #
- X Week XX +67%
- X Month XX +2.10%
- X Months XXX +127%
- X Year XXX +225%
Followers: XXXXX #
- X Week XXXXX +2.40%
- X Month XXXXX +3.80%
- X Months XXXXX +42%
- X Year XXXXX +50%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXXX% finance XXXX% currencies XXXX%
Social topic influence $atai #6, $cybn 7.91%, atai life #6, $cmps 3.6%, $mnmd 3.6%, $ghrs 2.88%, investment 2.16%, $anro 1.44%, $vtgn 1.44%, $abbv XXXX%
Top accounts mentioned or mentioned by @c2412345 @brandon_job23 @cangermayer @psychedalpha @fiwlsp @insidepharma @kukeon2022 @beckleypsytech @atailife @alphaporgs @brandonjob23 @jedisrle @bigdogback @smallpharma @cangermayers @hildeshiem1 @nftlunatic @investingincan1 @zetaboy69 @mattbro32211486
Top assets mentioned ATAI Life Sciences (ATAI) AbbVie Inc (ABBV) Hundred Million (100M)
Top Social Posts #
Top posts by engagements in the last XX hours
"@C_Angermayer @atai_life Congratulations @C_Angermayer and to the entire team at @atai_life and @BeckleyPsytech"
X Link @PsychedVantage 2025-10-17T12:42Z 1521 followers, XXX engagements
"We shall see. If we take the rumors seriously from the recent piece put out by @Bloomberg then perhaps it wouldnt be so surprising. Separately Atai Life Sciences NV is working with an investment bank to field early stage interest from major industry players the people said. The Peter Thiel-backed firm which recently acquired Beckley Psytech has received positive results from a recent mid-stage trial of a psychedelic nasal spray dubbed BPL-003. A representative for Atai declined to comment. Time will tell. -Jake"
X Link @PsychedVantage 2025-08-21T16:17Z 1498 followers, XXX engagements
"atai Life Sciences Awarded Grant from the National Institutes of Health $ATAI"
X Link @PsychedVantage 2025-09-18T13:31Z 1497 followers, 2616 engagements
"When/if Pharma makes another move on short acting psychedelics which program is their most likely target $CYBN $ATAI $GHRS"
X Link @PsychedVantage 2025-09-29T15:02Z 1504 followers, XXX engagements
"$ATAI $ARKG"
X Link @PsychedVantage 2025-10-07T01:20Z 1499 followers, 2118 engagements
"$ATAI October 2025 Corporate Presentation"
X Link @PsychedVantage 2025-10-07T15:11Z 1499 followers, 2723 engagements
"@c2412345 @Matt_vlietstra @Thegaucher1 Ya I sold out for a loss. Only individual stocks I hold rn are $ATAI $CMPS $ANRO and $VTGN. I could potentially see myself re-entering $CYBN at some point. We shall see. -Jake"
X Link @PsychedVantage 2025-10-09T15:21Z 1505 followers, XXX engagements
"AbbVie acquired Gilgameshs GM-2505 (bretisilocin) in a deal worth up to $1.2B. The upfront wasnt disclosed. Whats your estimate for the upfront payment (No royalties mentioned; GM-2505 has been IV in trials with an IM formulation planned) $CMPS $MNMD $CYBN $ATAI $GHRS"
X Link @PsychedVantage 2025-09-01T20:59Z 1510 followers, 1266 engagements
"Updated neuropsychiatry drug development portfolio allocation (Individual + Roth IRA) Today I sold around XX% of my $ATAI position and for a simple reason: Not only was $ATAI very overweight in my neuropsychiatry drug development portfolio it was starting to make up an uncomfortably large share of my overall net worth. (I still think this stock has a lot of upside potential in the short medium and longterm/not financial or investment advice). As always this is not investment advice. I share to stay transparent and spark conversation in the community. -Jake"
X Link @PsychedVantage 2025-09-23T20:48Z 1505 followers, 3358 engagements
"Some personal thoughts/opinions/predictions (I reserve the right to be wrong): $CMPS $MNMD $CYBN $ATAI $GHRS $CMPS COMP005 XX week data could underwhelm investors (potentially being shared in Q1 2026 though no official guidance from $CMPS yet as far as Im aware). As I have shared many times I am much more bullish on COMP006 data. BPL-003 will eventually be granted BTD. $ATAI needs more cash. Will they partner up Raise a new round What valuation will healthcare investors be comfortable with $CMPS head start in the space may be more than some anticipated. With more companies running large phase"
X Link @PsychedVantage 2025-09-25T19:58Z 1505 followers, 2911 engagements
"Although 5-MeO-DMT is in later stages of development and has shown a lot of promise: for the treatment of depression/anxiety specifically I am most excited about the potential of NN-DMT. Great to see $ATAI and $CYBN using two-dose induction models in their phase X trials in TRD and GAD (with co-morbid depression allowed). Most optimistic about the potential of 5-MeO-DMT for substance use disorders. (Not included on list)-Does atai/Beckley find a buyer for ELE-101 I like the idea of a short-acting psilocybin-like candidate (Perhaps a better tolerated psychedelic when compared to NN/5-MeO-DMT)"
X Link @PsychedVantage 2025-09-29T15:02Z 1504 followers, XXX engagements
"Updated neuropsychiatry drug development portfolio allocation (Individual + Roth IRA) I cut losses with $CYBN and spread money around to $ATAI $CMPS $VTGN $NEUP (new position) $VOO and $VTI As always this is not investment advice. I share to stay transparent and spark conversation in the community. -Jake"
X Link @PsychedVantage 2025-09-30T16:01Z 1504 followers, 3132 engagements
"Updates: Chickened out and sold $NEUP for a XX% gain. Not investment advice. -Jake"
X Link @PsychedVantage 2025-10-07T13:43Z 1514 followers, XXX engagements
"Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones $CYBN"
X Link @PsychedVantage 2025-09-23T21:05Z 1515 followers, XXX engagements
"I like $MNMD. Just like the other names I currently hold more. I could see myself potentially buying some in the future. Yeah to me at least a bet on $CYBN is a bet that they partner up for both CYB003 and CYB004 or get bought out. I think CYB004 is a special program excited to see data when it is released in Q1 2026. Not quite convinced yet that CYB003 is that much differentiated from COMP360. -Jake"
X Link @PsychedVantage 2025-10-09T15:49Z 1515 followers, XXX engagements
"atai Life Sciences Announces Proposed Public Offering of Common Shares $ATAI"
X Link @PsychedVantage 2025-10-16T20:16Z 1518 followers, 2148 engagements
"Cybin to Participate in the Cantor Global Healthcare Conference 2025 $CYBN"
X Link @PsychedVantage 2025-09-03T11:31Z 1515 followers, 1030 engagements
"The Complete Response Letter (CRL) issued to Lykos Therapeutics is now publicly available $CMPS $MNMD $CYBN $ATAI $GHRS"
X Link @PsychedVantage 2025-09-04T16:08Z 1515 followers, 2397 engagements
"Cybin Completes Enrollment in Phase X Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder $CYBN"
X Link @PsychedVantage 2025-09-08T11:31Z 1515 followers, 1056 engagements
"Indeed. Very exciting news. 🐸 Interested to see the pricing of the proposed public offering. $ATAI"
X Link @PsychedVantage 2025-10-16T21:09Z 1520 followers, 2392 engagements
"atai Life Sciences Announces Pricing of Public Offering of Common Shares $ATAI"
X Link @PsychedVantage 2025-10-17T02:33Z 1520 followers, 3033 engagements
"Close Priced at $XXXX. Great to see $ATAI raising at this valuation curious to see which investors participated when that list comes out"
X Link @PsychedVantage 2025-10-17T02:41Z 1520 followers, 2486 engagements
"AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin"
X Link @PsychedVantage 2025-10-17T14:33Z 1518 followers, XXX engagements
"$MNMD surpasses $X billion dollar market cap"
X Link @PsychedVantage 2025-10-17T19:42Z 1521 followers, XXX engagements